These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 7533406

  • 1. Significance of newly developed liposomal FK 506 in canine liver transplantation.
    Ko S, Nakajima Y, Kanehiro H, Horikawa M, Yoshimura A, Taki J, Kido K, Aomatsu Y, Ueno M, Kin T.
    Transplant Proc; 1995 Feb; 27(1):351-3. PubMed ID: 7533406
    [No Abstract] [Full Text] [Related]

  • 2. Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation.
    Ko S, Nakajima Y, Kanehiro H, Horikawa M, Yoshimura A, Kido K, Taki J, Aomatsu Y, Kin T, Yagura K, Ohyama T, Ohashi K, Yamada T, Nakano H.
    Transplant Proc; 1996 Apr; 28(2):1066-8. PubMed ID: 8623229
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
    Sher LS, Cosenza CA, Petrovic LM, Rojter S, Hoffman A, Lopez RR, Meehan M, Pan SH, Vierling J, Makowka L.
    Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212
    [No Abstract] [Full Text] [Related]

  • 4. Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506.
    Velio P, Tarantino C, Bertoglio C, Guffanti E, Bardella MT, Biffi R, Andreoni B, Rossi G, Gatti S, Piazzini A, Fassati LR, Galmarini D.
    Transplant Proc; 1996 Oct; 28(5):2529-30. PubMed ID: 8907936
    [No Abstract] [Full Text] [Related]

  • 5. Predominant role of local immunosuppressive effect in enhanced efficacy of liposomal FK506 in organ transplantation.
    Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Horikawa M, Aomatsu Y, Yagura K, Kin T, Ohyama T, Nishio K, Yamada T, Nakano H.
    Transplant Proc; 1997 Oct; 29(1-2):529-31. PubMed ID: 9123117
    [Abstract] [Full Text] [Related]

  • 6. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
    Jacob DA, Neumann UP, Bahra M, Langrehr JM, Neuhaus P.
    Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432
    [Abstract] [Full Text] [Related]

  • 7. Tolerance induction by liver grafting and FK 506 treatment in nonhuman primates.
    Gotoh M, Monden M, Kanai T, Umeshita K, Wang K, Ukei T, Dono K, Tono T, Murata M, Tanimoto J.
    Transplant Proc; 1991 Dec; 23(6):3265-8. PubMed ID: 1721431
    [No Abstract] [Full Text] [Related]

  • 8. The significance of local immunosuppression in canine liver transplantation.
    Ko S, Nakajima Y, Kanehiro H, Taki J, Aomatsu Y, Yoshimura A, Yagura K, Kin T, Ohashi K, Nakano H.
    Transplantation; 1994 Jun 27; 57(12):1818-21. PubMed ID: 8016890
    [No Abstract] [Full Text] [Related]

  • 9. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Oct 27; 9(5):406-14. PubMed ID: 8541635
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppressive effect of FK506 on orthotopic liver and small bowel xenotransplantation (xenoOLTx and SBTx).
    Zou XM, Yagihashi A, Tsuruma T, Matsuno T, Yamaguchi H, Asanuma K, Sasaki K, Hirata K.
    Transplant Proc; 1996 Jun 27; 28(3):1437-9. PubMed ID: 8658729
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.
    Bismuth H.
    Transplant Proc; 1995 Feb 27; 27(1):45-9. PubMed ID: 7533415
    [No Abstract] [Full Text] [Related]

  • 12. Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up.
    Jonas S, Neuhaus R, Junge G, Klupp J, Theruvat T, Langrehr JM, Settmacher U, Neuhaus P.
    Int Immunopharmacol; 2005 Jan 27; 5(1):125-8. PubMed ID: 15589470
    [Abstract] [Full Text] [Related]

  • 13. The enhanced immunosuppressive efficacy of newly developed liposomal FK506 in canine liver transplantation.
    Ko S, Nakajima Y, Kanehiro H, Horikawa M, Yoshimura A, Taki J, Aomatsu Y, Kin T, Yagura K, Nakano H.
    Transplantation; 1995 May 27; 59(10):1384-8. PubMed ID: 7539553
    [Abstract] [Full Text] [Related]

  • 14. The minimum graft size for successful orthotopic partial liver transplantation in the canine model.
    Shirakata Y, Terajima H, Mashima S, Inomoto T, Nishizawa F, Saad S, Hong SJ, Morimoto T, Inamoto T, Yamaoka Y.
    Transplant Proc; 1995 Feb 27; 27(1):545-6. PubMed ID: 7533422
    [No Abstract] [Full Text] [Related]

  • 15. FK 506 treatment of intractable rejection after liver transplantation.
    Jost U, Winkler M, Ringe B, Rodeck B, Pichlmayr R.
    Transplant Proc; 1993 Aug 27; 25(4):2686-7. PubMed ID: 7689276
    [No Abstract] [Full Text] [Related]

  • 16. FK 506 inhibits tolerance induction in mice liver transplantation.
    Sugioka A, Morita M, Kato T, Hoshimoto S, Fujita J, Morise Z, Hasumi A.
    Transplant Proc; 2005 Aug 27; 37(1):146-7. PubMed ID: 15808576
    [Abstract] [Full Text] [Related]

  • 17. Comparative efficacy of liposomal FK506 with FK506.
    Moffatt SD, McAlister V, Calne RY, Metcalfe S.
    Transplant Proc; 1998 Dec 27; 30(8):4066-7. PubMed ID: 9865297
    [No Abstract] [Full Text] [Related]

  • 18. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO, Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Williams R, Ericzon BG, Bismuth H.
    Transplant Proc; 1996 Apr 27; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract] [Full Text] [Related]

  • 19. Comparative efficacy of liposomal FK 506 with FK 506 (tacrolimus) with and without anti-CD4/CD8 monoclonal antibodies.
    Moffatt SD, McAlister V, Calne RY, Metcalfe SM.
    Transplant Proc; 1999 Nov 27; 31(7):2754. PubMed ID: 10578277
    [No Abstract] [Full Text] [Related]

  • 20. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):679-88. PubMed ID: 7679840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.